These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3285834)

  • 1. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
    Klütsch K; Grosswendt J; Haecker W
    Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
    Mourad G; Haecker W; Mion C
    Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacodynamics of torasemide and furosemide in patients with oedema.
    Herchuelz A; Deger F; Douchamps J; Ducarne H; Broekhuysen J
    Arzneimittelforschung; 1988 Jan; 38(1A):180-3. PubMed ID: 3285831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
    Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
    Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
    Brunner G; von Bergmann K; Häcker W; von Möllendorff E
    Arzneimittelforschung; 1988 Jan; 38(1A):176-9. PubMed ID: 3285830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.
    Stroobandt R; Dodion L; Kesteloot H
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):151-8. PubMed ID: 6762167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure.
    Boesken WH; Kult J
    Clin Nephrol; 1997 Jul; 48(1):22-8. PubMed ID: 9247774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torasemide in advanced renal failure.
    Kindler J
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():75-80. PubMed ID: 8435381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torasemide for diuretic treatment of advanced chronic renal failure.
    Clasen W; Khartabil T; Imm S; Kindler J
    Arzneimittelforschung; 1988 Jan; 38(1A):209-11. PubMed ID: 3285836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
    Scheen AJ; Vancrombreucq JC; Delarge J; Luyckx AS
    Eur J Clin Pharmacol; 1986; 31 Suppl():35-42. PubMed ID: 3780838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of torasemide in patients with chronic heart failure.
    Achhammer I; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):184-7. PubMed ID: 3285832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bumetanide, a new diuretic.
    Hofstetter A
    Int Urol Nephrol; 1974; 6(1):35-42. PubMed ID: 4617729
    [No Abstract]   [Full Text] [Related]  

  • 14. TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
    Díez J; Coca A; de Teresa E; Anguita M; Castro-Beiras A; Conthe P; Cobo E; Fernández E;
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):897-904. PubMed ID: 19673667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of inhaled furosemide and torasemide on bronchial response to ultrasonically nebulized distilled water in asthmatic subjects.
    Foresi A; Pelucchi A; Mastropasqua B; Cavigioli G; Carlesi RM; Marazzini L
    Am Rev Respir Dis; 1992 Aug; 146(2):364-8. PubMed ID: 1489126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Torasemide (Trifas) in clinical practice--own experience].
    Grajewska M; Sulikowska B; Manitius J
    Przegl Lek; 2003; 60(1):24-6. PubMed ID: 12884642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torasemide, a new loop diuretic, in patients with chronic renal failure.
    Russo D; Gazzotti RM; Testa A
    Nephron; 1990; 55(2):141-5. PubMed ID: 2194134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study.
    Laffi G; Marra F; Buzzelli G; Azzena G; Meacci E; De Feo ML; La Villa G; Gentilini P
    Hepatology; 1991 Jun; 13(6):1101-5. PubMed ID: 2050329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.
    Spannbrucker N; Achhammer I; Metz P; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.